NON-FINAL ACTION - MAILED
final action
on 30 Sep 2024
Last Applicant/ Owned by
Brisbane City QLD 4000
AU
Serial Number
79397452 filed on 14th Mar 2024
Registration Number
N/A
Correspondent Address
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
GENE COMPANY
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of novel RNA nanoparticle technologies for medical and scientific applications; providing medical and scientific research in the fields of pharmaceutic Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of novel RNA nanoparticle technologies for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacture of pharmaceutical products including manufacture of pharmaceutical preparations containing RNA, nucleic acids, protein nanoparticles; providing information in the field of custom manufacture of pharmaceuticals.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Medical, biological, and pharmaceutical preparations for medical laboratory use; vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, preparations containing novel RNA nanoparticle technologies; nanoparticle formulations for pharmaceutical, medical or medical diagnostic purposes; drug delivery agents for medical use consisting of RNA nanoparticle formulations that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations comprising drug delivery agents based on RNA nanoparticle formulations; pharmaceutical preparations, namely, RNA and delivery agents comprised of nanoparticle carriers and polymers for the delivery of RNA to human cells.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Chemical, biological, and bacteriological preparations for scientific and research use, or for the manufacture of pharmaceuticals; chemical, biological, and bacteriological preparations for scientific and research use, or for the manufacture of pharmaceuticals, namely, preparations containing RNA nanoparticle technologies; RNA nanoparticles for scientific, laboratory or medical research use.
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79397452
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Design Code(s)
26.01.29 -
Helixes
Legal History
| Status Date | Action Taken |
|---|---|
| 19th Oct 2024 | REFUSAL PROCESSED BY IB |
| 30th Sep 2024 | REFUSAL PROCESSED BY MPU |
| 30th Sep 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 26th Sep 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 25th Sep 2024 | NON-FINAL ACTION WRITTEN |
| 24th Sep 2024 | ASSIGNED TO EXAMINER |
| 20th Jun 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| 20th Jun 2024 | APPLICATION FILING RECEIPT MAILED |
| 13th Jun 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |